Author | Mojibade N. Hassan


Treating Chemotherapy-Induced Thrombocytopenia: Is It Time for Oncologists to Use Thrombopoietin Agonists?

April 15, 2015

ByMojibade N. Hassan|Edmund K. Waller, MD, PhD, FACP

Clinical trials of the new thrombopoietin receptor agonists in the management of chemotherapy-induced thrombocytopenia are needed to address concerns about the safety and practical efficacy new agents before we accept them as standard therapies.